State Ledger
Company profile

ZEVRA THERAPEUTICS, INC. CIK 1434647

Ticker
ZVRA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Boston, MA 02110
Fiscal year end
2025 (FY)
Market Data
Close
$10.22
Change
-$0.17
Change %
-1.64%
Volume
57,892

ZVRA · trading date Oct 14, 2026 · previous close $10.39 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
$83.23M
Total assets
$284.73M
Total liabilities
$130.07M
Stockholders' equity
$154.66M
Cash & equivalents
$62.41M
Operating income
-$62.94M
Operating cash flow
-$1.60M
Capital expenditures
$835.0K

Fiscal year 2025, via 10-K filed 2026-03-09. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$2.43M
Free cash flow margin
—
Liabilities / assets
45.7%
Equity / assets
54.3%
CapEx / revenue
—
Operating cash flow / net income
-0.02×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — $83.23M $284.73M $130.07M $154.66M
2024 — -$105.51M $178.13M $138.46M $39.67M
2023 — -$46.05M $172.33M $110.46M $61.86M
2022 — -$26.77M $115.34M $40.22M $75.12M
2021 — -$8.56M $132.94M $5.82M $101.66M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-17
Financials filed via
Form 10-K
filed 2026-03-09

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Boston, MA 02110
101 FEDERAL STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies